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A B S T R A C T
Lower respiratory infections are the most important cause of death due to a transmissible disease. We present a
case of severe influenza and coccidioidomycosis lung coinfection in a 65-year-old Mexican migrant. This case
highlights the challenges that respiratory viruses impose on the diagnosis of fungal infections and on the mul-
tidisciplinary management of these infections. In addition, this case shows how medical complications and
superinfections could be potentially prevented if flu vaccination is provided.
1. Introduction
Lower respiratory infections are the most important cause of death
due to a transmissible diseases [1]. Annually, influenza causes an
average of 54 millions of lower respiratory tract infections (LRTIs)
worldwide from which, 15% are severe LRTIs causing between 290,000
to 645,000 deaths [2,3]. Mixed infections or coinfections between in-
fluenza and bacteria occur in 11% to 35% of the cases of severe influ-
enza [4]. Coinfection with bacterial pathogens complicates the man-
agement of influenza infection and also, increases the severity of the
respiratory symptoms and the mortality. Multiple factors favour bac-
terial superinfections in severe influenza for example: pulmonary epi-
thelial damage by the virus, increased receptor availability, virus effects
on immunity to bacteria (impairing phagocytosis and killing) and, in-
creased inflammation [5].
In recent years, a new influenza-associated infection has been re-
ported. Influenza-associated pulmonary aspergillosis (IAPA) has been
reported more frequently after 2009 influenza pandemic [6,7] and
occurs between 14-28% of severe influenza cases [8–10]. IAPA in-
creases the need of ICU admissions, renal replacement therapy and
length of hospital stay in individuals with severe influenza [8,11]. In
individuals with COPD and influenza, pulmonary aspergillosis is three
times more frequent than in individuals with either only influenza or
COPD alone [12].
We report a different influenza-associated fungal infection in a 65-
year-old man admitted to ICU unit due to acute respiratory distress
syndrome. Coinfection between influenza and coccidioidomycosis was
diagnosed. During the ICU stay, the patient required invasive me-
chanical ventilation, a wide multidisciplinary approach, renal replace-
ment therapy, broad-range spectrum antibiotics and antifungal agents.
Coccidioidomycosis should be considered in the differential diagnosis
of returning migrants and travellers from endemic regions. The role of
influenza on the local immunity may play a major role on the severe
reactivation of coccidioidomycosis.
2. Case presentation
On 30th January 2020, a Mexican 65-year-old man presented to the
emergency department with 24 h progressive shortness of breath and
was admitted to ICU unit for invasive mechanical ventilation. He was a
previous resident of California (USA) and, he flew back to Michoacán
(México) 3 months before admission. A month before admission, the
patient had respiratory symptoms that partially improved over time. A
week before admission, new fever, myalgia, arthralgias and, dyspnoea
made the respiratory symptoms worst. At the admission, physical ex-
amination showed temperature of 37 °C, blood pressure 75/40 mmHg
(norepinephrine at 0.2 μg/min was started after fluid IV infusion), pulse
125 bpm. Blood tests showed creatinine 1.7 mg/ml (patient was
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anuric), procalcitonin 58 ng/ml, pH 7.41, PaCO2 = 21 mmHg,
PaO2 = 51 mmHg, HCO3 = 16⋅9, lactate 8⋅4, haemoglobin 11⋅1 g/dl,
WBC count 8800 per μl (lymphocytes 12%, 7% bands), platelet count
160,000 per μl. Control of these blood parameters were performed
every other day. After tracheal intubation, a chest X-ray showed bi-
lateral infiltrates and multiple opacities (Fig. 1). After cultures were
recovered, antimicrobial treatment with carbapenem, clarithromycin,
oseltamivir and voriconazole was initiated. Oral voriconazole (400
mg b.i.d on the first day, followed by 200 mg b.i.d) was administered
via a nasogastric tube. A rapid test was positive for Influenza A. The
patient never received previous influenza vaccination. Family denied
the patient having a previous chronic disease but at ICU, HbA1c test
was 8.4%, which leaded the ICU team to think the patient had an un-
treated undiagnosed diabetes condition.
On day 3 of ICU stay, bronchoalveolar lavage was performed,
abundant and purulent secretions and biopsies were collected for cul-
tures, PCR panel (to identify 16 viruses and 7 bacteria) and histo-
pathological analyses. An HIV test resulted negative. At day 5, acute
respiratory distress syndrome was diagnosed and amphotericin B
deoxycholate (at 1 mg/kg/day) was added due to preliminary histo-
pathological findings. On the 8th day of stay, the patient died.
Histopathology results reported structures compatible with spher-
ules containing endospores, chronic inflammation in bronchi and pul-
monary tissue. Also, focal oedema, vascular congestion, coagulative
necrosis and multifocal haemorrhages were seen in tissue (Fig. 2).
Coccidioides sp grew on three different culture media (blood, chocolate
and Sabouraud agars) after two days of incubation (no bacteria were
identified) and was confirmed by MALDI-TOF. The viral panel identi-
fied influenza A (H1N1). The final diagnosis of this patient was severe
pulmonary coccidioidomycosis and influenza A (H1N1) mixed infec-
tion.
3. Discussion
To our knowledge, this is the first case reporting a coinfection be-
tween severe influenza and pulmonary coccidioidomycosis. The noti-
fication system in the United States has shown that, cases of cocci-
dioidomycosis have increased in non-endemic (Washington state) and
endemic regions specially in California and Arizona [13]. In Mexico,
notification of coccidioidomycosis cases is not compulsory. However,
up to 90% of the population in the neighbouring Northern Mexican
states have a positive skin test for coccidioidomycosis, which allows an
estimation on how frequent this fungal infection is in these areas [14].
Coccidioidomycosis is one of the infections that could potentially in-
crease in frequency in the next coming years as result of climate change
Fig. 1. Clinical findings in a patient with pulmonary coccidioidomycosis
and Influenza A H1N1 mixed infection. Posteroanterior chest X-ray. After
tracheal intubation on the first day in the ICU, the chest ray showed bilateral
infiltrates and multiple opacities.
Fig. 2. Histopathological findings in
bronchial and pulmonary tissue.
Three different staining techniques
were used. Haematoxylin and eosin
staining (A, B) showing chronic in-
flammation characterised by in-
filtrating cells (lymphocytes, histo-
cytes, plasmatic cells). (A) Vascular
congestion, oedema, coagulative ne-
crosis and multifocal haemorrhages are
seen, incomplete granulomas sur-
rounding spherules (black arrows), and
(B) spherules containing endospores
(punctate arrows). Periodic acid
staining (C), show several forms of
spherules, empty spherules (punctate
arrows), spherules containing en-
dospores (black arrows). (D)
Methenamine silver staining shows a
big spherule containing endospores
stained in brown (black arrow). (For
interpretation of the references to
colour in this figure legend, the reader
is referred to the Web version of this
article.)
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as the frequency of this fungal infection is closely correlated with dust
storms [15]. Coccidioidomycosis is also an infection to be considered in
the differential diagnosis of returning migrants and travellers [16].
Usually, 60% of the coccidioidomycosis cases are asymptomatic and,
severe pneumonia with ARDS and/or dissemination occurs in< 2% of
the cases [16]. Diabetic individuals with extensive pulmonary cocci-
dioidomycosis have higher risk of dissemination; in this group of pa-
tients, antifungal treatment is recommended with an orally absorbed
azole [16]. Only few cases of tuberculosis and blastomycosis in co-in-
fection with coccidioidomycosis have been rarely reported and worse
outcomes are seen in HIV/AIDS individuals [17,18].
As mentioned above, it is thought that influenza virus would favour
bacterial superinfection by damaging the pulmonary epithelial cells. In
the current case it is possible that the patient had first coccidioidomy-
cosis and then the influenza superinfection. Hence, the role of influenza
on the local immunity could be playing the major role on a potential
severe reactivation of coccidioidomycosis occurring in this patient.
After inhalation of arthroconidia and spherule production in the lung,
the response to coccidioidomycosis consists essentially on fungal con-
tainment by phagocytosis carried out by macrophages and neutrophils,
high production of TNFα, IFNγ, and IL-17 and CD4+ T cell response
[19]. One of the effects of influenza on local immunity is the induction
of type I interferon responses, which has a paradoxical effect on mac-
rophages and neutrophils functions, especially on phagocytosis and
early killing [5]. An in vitro study showed that viral infection triggers
interferon-induced expulsion of live Cryptococcus neoformans previously
phagocyted by macrophages [20]. This could be a potential triggering
factor for reactivation of fungal infections such as coccidioidomycosis.
This clinical case illustrates the new diagnostic and therapeutic
challenges that respiratory viruses impose on fungal infections, and also
highlights the importance of flu vaccination in preventing not only
more severe influenza but also severe superinfections.
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